Immediate Anticoagulation with Heparin, Not Eliquis
You should immediately initiate anticoagulation with intravenous unfractionated heparin (bolus 5000 IU or 70-100 IU/kg, followed by continuous infusion) or subcutaneous low molecular weight heparin (enoxaparin 1 mg/kg twice daily), not apixaban (Eliquis), while arranging urgent vascular surgery consultation. 1 The arterial ultrasound finding is sufficient to act upon—you do not need Doppler confirmation before starting anticoagulation, as any delay increases the risk of thrombus propagation and limb loss.
Why Heparin, Not Eliquis?
Eliquis (apixaban) is FDA-approved only for venous thromboembolism (DVT/PE) and atrial fibrillation-related stroke prevention—not for acute arterial thrombosis. 2 The drug label makes no mention of arterial limb ischemia as an indication. In contrast, ACC/AHA guidelines explicitly recommend immediate heparin anticoagulation for acute limb ischemia to prevent further embolization and thrombus propagation. 3
The 2024 ESC guidelines reinforce this approach, stating that upon clinical diagnosis of acute limb ischemia, you should "initiate analgesia, anticoagulation, and i.v. fluids" with either unfractionated heparin or low molecular weight heparin. 1 This is the standard of care for arterial thrombosis.
Diagnostic Confirmation
Your arterial ultrasound showing thrombus in the distal superficial femoral artery extending into the popliteal artery is diagnostic. While duplex Doppler ultrasound can provide additional hemodynamic information, it should not delay treatment. 1 The 2024 ESC guidelines explicitly note that imaging "should not delay treatment" in acute limb ischemia.
If you want additional imaging for surgical planning:
- CTA is preferred if time permits and renal function allows—it reveals the exact nature and level of thrombosis and underlying atherosclerotic plaque 3
- Duplex ultrasound is appropriate if CTA is contraindicated (renal dysfunction, contrast allergy) 3
- The ultrasound you already have is sufficient to start anticoagulation immediately
Clinical Assessment of Limb Viability
Before proceeding, assess limb viability using the "6 Ps":
- Pain, Paralysis, Paresthesias, Pulselessness, Pallor, Polar (cold)
The 2024 ESC classification system helps determine urgency: 1
- Viable limb (no sensory loss, normal motor function) → urgent revascularization
- Threatened limb (sensory loss in toes, mild-moderate weakness) → emergency revascularization
- Irreversible (complete sensory/motor loss) → consider primary amputation
Definitive Management Algorithm
- Start heparin immediately (as detailed above)
- Urgent vascular surgery consultation within hours, not days
- Evaluate for hypercoagulability concurrently: PT, PTT, platelet count, factor V Leiden, prothrombin C-20210a, protein C/S, antithrombin III 3
- Revascularization options (vascular surgery will decide):
Common Pitfalls to Avoid
Do not use oral anticoagulants like Eliquis as initial therapy for acute arterial thrombosis. The rapid onset and reversibility of heparin make it the only appropriate choice. Heparin can be monitored with aPTT or anti-Xa levels and reversed quickly if bleeding complications occur or urgent surgery is needed.
Do not delay anticoagulation waiting for additional imaging. The ultrasound finding of arterial thrombus is sufficient. Every hour of delay increases the risk of thrombus propagation into tibial vessels, which dramatically worsens limb salvage rates. 4
Do not mistake this for a venous problem. The superficial femoral artery (despite its confusing name) is part of the arterial system, not the superficial venous system. 5 This is arterial thrombosis requiring urgent intervention to prevent limb loss.
Post-Revascularization Considerations
After successful revascularization, investigate the underlying cause:
- Popliteal artery aneurysm is a common culprit for this anatomic distribution of thrombus 4
- Check for bilateral popliteal aneurysms (50% are bilateral) 4
- Screen for abdominal aortic aneurysm (associated in 40% of cases) 4
- Consider cardiac sources of embolism: atrial fibrillation, ventricular aneurysm, endocarditis 4
Long-term anticoagulation decisions depend on the underlying etiology identified during workup, not on the acute presentation.